A carregar...
Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs
Geraint Davies and colleagues discuss the potential for innovative early-phase clinical trial methods and technologies to reduce risk and speed up drug development for tuberculosis.
Na minha lista:
| Publicado no: | PLoS Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6615592/ https://ncbi.nlm.nih.gov/pubmed/31287813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1002851 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|